3 No-Brainer Healthcare Stocks to Buy Right Now

Earlier in the pandemic, coronavirus products boosted the revenue and the stock prices of companies selling those products. But these days, those products actually have done just the opposite, dragging down performance.

It's important to keep in mind, though, that some of these players offer (or are set to offer) revenue growth well beyond the coronavirus portfolio. So right now, with their shares trading at bargain prices, they've become no-brainer buys.

Which companies am I talking about? Coronavirus testing giant Abbott Laboratories (NYSE: ABT) and vaccine leaders Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE). Let's take a closer look at each of these stocks as possible buys right now.

Source Fool.com

Pfizer Inc. Aktie

Pfizer Inc. muss heute Verluste wegstecken. Die Aktie notiert im Vergleich zu gestern um -2,85 % tiefer.
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.61 € bedeuten.

Like: 0

ABT

Teilen